Dr. Wesley Lyle Baber, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Fuller St, Alexandria Bay, NY 13607 Phone: 315-482-1239 Fax: 315-482-4847 |
Harriet L Burris, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Fuller St, River Hospital, Alexandria Bay, NY 13607 Phone: 315-482-1111 Fax: 315-482-4981 |
News Archive
The smoking cessation drug Champix (sold in the US as Chantix) has allegedly made fifteen people commit suicide since January 2008 in Australia. Another 191 patients have reported suicidal thoughts and related effects. The latest available figures from the Therapeutic Goods Administration (TGA) suggest a doubling in the numbers of suicides linked to Champix (Varenicline) since July last year with six people committing suicide.
According to George Kappler, "If hospitals were subjected to the same protection standards as factories, many would have been shut down a long time ago." Those are tough words for healthcare workers to hear as they brace for an onslaught of H1N1 patients, but the CEO of Kappler, Inc., a 33-year veteran in the protective garment business, knows of what he speaks.
The ability of the Food and Drug Administration (FDA) to regulate the safety of dietary supplements using nanomaterials is severely limited by lack of information, lack of resources and the agency's lack of statutory authority in certain critical areas, according to a new expert report released by the Project on Emerging Nanotechnologies (PEN).
Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Applications (ANDAs) for Lamotrigine Tablets.
› Verified 6 days ago